Skip to content
Subscriber Only

Teva Buys 1.35% of Mylan Shares to Pressure Takeover Target

Updated on

Teva Pharmaceutical Industries Ltd. bought

1.35 percent of Mylan NV’s stock on the open market, putting pressure on the rival drugmaker to accept a takeover offer.